Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study

The COVID-19 outbreak continues to spread worldwide at a rapid rate. Currently, the absence of any effective antiviral treatment is the major concern for the global population. The reports of the occurrence of various point mutations within the important therapeutic target protein of SARS-CoV-2 has...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Mohammad Hassan, Sharma, Tanuj, Ahmad, Irfan, Abohashrh, Mohammed, Alam, Mohammad Mahtab, Dong, Jae-June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002701/
https://www.ncbi.nlm.nih.gov/pubmed/33802860
http://dx.doi.org/10.3390/molecules26061678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002701/
https://www.ncbi.nlm.nih.gov/pubmed/33802860
http://dx.doi.org/10.3390/molecules26061678

Ejemplares similares